FY2024 EPS Estimates for Option Care Health, Inc. (NASDAQ:OPCH) Boosted by William Blair

Option Care Health, Inc. (NASDAQ:OPCH) – Research analysts at William Blair increased their FY2024 EPS estimates for shares of Option Care Health in a research report issued to clients and investors on Wednesday, April 24th. William Blair analyst M. Larew now forecasts that the company will post earnings per share of $1.19 for the year, up from their prior forecast of $1.17. The consensus estimate for Option Care Health’s current full-year earnings is $1.17 per share. William Blair also issued estimates for Option Care Health’s Q1 2025 earnings at $0.30 EPS, Q2 2025 earnings at $0.35 EPS, Q4 2025 earnings at $0.41 EPS and FY2025 earnings at $1.43 EPS.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The firm had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. Option Care Health’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.21 earnings per share.

A number of other equities analysts have also recently weighed in on the stock. Jefferies Financial Group upped their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. Barrington Research reiterated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday.

Option Care Health Stock Up 1.1 %

Option Care Health stock opened at $29.61 on Thursday. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74. The business’s 50-day moving average price is $31.96 and its 200 day moving average price is $31.48. Option Care Health has a 52 week low of $24.23 and a 52 week high of $35.74. The firm has a market cap of $5.15 billion, a price-to-earnings ratio of 19.48, a price-to-earnings-growth ratio of 1.65 and a beta of 1.22.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Wellington Management Group LLP grew its position in shares of Option Care Health by 157.1% during the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock worth $250,841,000 after acquiring an additional 4,549,164 shares during the last quarter. Vanguard Group Inc. grew its position in Option Care Health by 11.8% during the 3rd quarter. Vanguard Group Inc. now owns 19,319,352 shares of the company’s stock worth $624,981,000 after purchasing an additional 2,037,162 shares during the last quarter. Third Point LLC increased its stake in Option Care Health by 55.7% in the third quarter. Third Point LLC now owns 5,450,659 shares of the company’s stock valued at $176,329,000 after purchasing an additional 1,950,659 shares during the period. Norges Bank purchased a new stake in shares of Option Care Health in the fourth quarter valued at about $64,343,000. Finally, Assenagon Asset Management S.A. acquired a new stake in shares of Option Care Health during the third quarter worth about $36,239,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of Option Care Health stock in a transaction that occurred on Monday, February 26th. The stock was purchased at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the transaction, the director now directly owns 269,528 shares in the company, valued at $8,503,608.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.